Get started
Author

Katherine Cynthia Rappazzo

Observed names: K. C. Rapazzo, K. C. Rappazzo, K. Rapazzo, KC Rappazzo, Katherine C Rappazzo, Katherine C. Rappazzo, Katherine Rappazzo
Observed institutions: Johns Hopkins University, Vanderbilt University, Johns Hopkins Medicine, University of California San Diego, Johns Hopkins Hospital, Sidney Kimmel Comprehensive Cancer Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
ORCID: 0000-0001-6616-5041
Observed ORCID: 0000-0001-6616-5041
OpenAlex ID: A5071841968
Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma
2017 · M.H. Pollack, A. Betof, et al. · Annals of Oncology · 393
Checkpoint inhibitor‐based salvage regimens prior to autologous stem cell transplant improve event‐free survival in relapsed/refractory classic Hodgkin lymphoma
2023 · Sanjal H. Desai, Michael A. Spinner, et al. · American Journal of Hematology · 33
PDF
Nonmyeloablative, HLA-Mismatched Unrelated Peripheral Blood Transplantation with High-Dose Post-Transplantation Cyclophosphamide
2021 · Katherine C. Rappazzo, Marianna Zahurak, et al. · Transplantation and Cellular Therapy · 17
Pocket handheld ultrasound for evaluation of the bleeding haemophilic joint: A novel and reliable way to recognize joint effusions
2018 · J. Y. Zhou, K. C. Rappazzo, et al. · Haemophilia · 16
Using theHER2/CEP17FISH Ratio to Predict Pathologic Complete Response Following Neoadjuvant Anti-HER2 Doublet Therapy in HER2+ Breast Cancer
2022 · Eric M Lander, Katherine C Rappazzo, et al. · The Oncologist · 14
PDF
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era
2023 · Sanjal H. Desai, Michael A Spinner, et al. · Blood Advances · 8
PDF
Patient expectations of benefit from systemic treatments for metastatic prostate cancer
2019 · Laura B. Oswald, Rachel Kasimer, et al. · Cancer Medicine · 7
PDF
Pigmented hidrocystoma of nasal epithelium (PHONE): report of a man with a pigmented hidrocystoma of his nose and literature review
2016 · Katherine C Rappazzo, Philip R Cohen · Dermatology Online Journal · 4
PDF
Outcomes of classic Hodgkin lymphoma, relapsed within one year of diagnosis, in the era of novel agents.
2022 · Sanjal Desai, Michael Alexander Spinner, et al. · Journal of Clinical Oncology · 3
Novel Salvage Regimens Lead to Better Response and Survival in Relapsed Refractory Classic Hodgkin Lymphoma after Autologous Stem Cell Transplant
2021 · Sanjal H Desai, Michael A Spinner, et al. · Blood · 3
Pocket Handheld Ultrasound As a Novel Point-of-Care Imaging Modality to Diagnose Bleeding in Hemophilic Joints
2016 · Jenny Y Zhou, Katherine C. Rappazzo, et al. · Blood · 3
Knee Fat Pad Volumes in Patients with Hemophilia and Their Relationship with Osteoarthritis
2017 · Annette von Drygalski, Katherine C. Rappazzo, et al. · Arthritis · 2
PDF
Outcomes of Autologous Stem Cell Transplant in Older Adults with Relapsed/Refractory Classic Hodgkin Lymphoma
2024 · Sanjal H. Desai, Michael A Spinner, et al. · Blood · 1
Overall survival in classic Hodgkin lymphoma pts who progress after autologous stem cell transplant in the era of novel agents
2023 · S. H. Desai, M. Spinner, et al. · Hematological Oncology · 1
PDF
Efficacy of brentuximab consolidation by metabolic response in an international real‐world cohort of classic Hodgkin lymphoma at high risk for progression after ASCT
2023 · S. H. Desai, A. Smith, et al. · Hematological Oncology · 1
PDF
Clinical correlates of response to anti-PD-1 (aPD1)-based therapy in patients (pts) with metastatic melanoma (MM).
2017 · Elizabeth J. Davis, Shilin Zhao, et al. · Journal of Clinical Oncology · 1
Safety of resuming anti-PD-1 (aPD1) in patients (pts) with immune-related adverse events (irAEs) during combined anti-CTLA-4 (aCTLA4) and aPD1 in metastatic melanoma (MM).
2017 · Megan Pollack, Allison Shayna Betof, et al. · Journal of Clinical Oncology · 1
Outcome heterogeneity in CALR ‐mutated myeloproliferative neoplasms
2026 · Resham Mawalkar, Hua‐Ling Tsai, et al. · British Journal of Haematology
PDF
Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma
2026 · Sanjal H. Desai, Susan M. Geyer, et al. · Blood Cancer Journal
PDF
High Molecular Risk Mutations (HMR) Drive Progression of CALR-mutated Myeloproliferative Neoplasm (MPN)
2024 · Resham Mawalkar, Hua-Ling Tsai, et al. · Blood
Checkpoint Inhibitors Based Salvage Regimens Lead to Higher Survival in Relapsed Refractory Classic Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant
2023 · Sanjal H Desai, Michael A Spinner, et al. · Transplantation and Cellular Therapy
CLO20-042: The HER2 FISH Ratio is a Predictor of Pathologic Complete Response Among Patients With HER2+ Breast Cancer Receiving Neoadjuvant Anti-HER2 Doublet Therapy Without Chemotherapy
2020 · Eric Lander, Ruey Hu, et al. · Journal of the National Comprehensive Cancer Network
Association between HER2 positivity by HER2/CEP17 ratio and response to neoadjuvant HER2 targeted therapy.
2018 · Katherine Cynthia Rappazzo, Heidi Chen, et al. · Journal of Clinical Oncology
Works count: 23
Citation count: 508
H-index: 7
I10-index: 5
Year
Topic
Type